Skybiotech Healthcar Stock Price Analysis and Quick Research Report. Is Skybiotech Healthcar an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Skybiotech Healthcar. 

• PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Skybiotech Healthcar has a PE ratio of -175.08557683412 which is low and comparatively undervalued.

• Return on Assets (ROA): Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Skybiotech Healthcar has ROA of 0.4944% which is a bad sign for future performance. (Higher values are always desirable.)

• Current ratio: The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Skybiotech Healthcar has a Current ratio of 0.217.

• Return on equity: ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Skybiotech Healthcar has a ROE of 0.528%. (Higher is better)

• Debt to equity ratio: It is a good metric to check out the capital structure along with its performance. Skybiotech Healthcar has a Debt to Equity ratio of 0 which means that the company has low proportion of debt in its capital.

• Sales growth: Skybiotech Healthcar has reported revenue growth of 0% which is poor in relation to its growth and performance. 

• Operating Margin: This will tell you about the operational efficiency of the company. The operating margin of Skybiotech Healthcar for the current financial year is 0%.

• Dividend Yield: It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Skybiotech Healthcar is Rs 0 and the yield is 0%.

• Earnings Per Share: It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Skybiotech Healthcar is Rs -1.0809. The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Skybiotech Healthcar in Ticker for free. Also, one can get the intrinsic value of Skybiotech Healthcar by using Valuation Calculators, which are available with a Finology ONE subscription. 

Skybiotech Healthcar FAQs

Q1. What is Skybiotech Healthcar share price today?
Ans: The current share price of Skybiotech Healthcar is Rs 189.25.

Q2. What is the market capitalisation of Skybiotech Healthcar?
Ans: Skybiotech Healthcar has a market capitalisation of Rs 36.241375 Cr., calculated based on its latest share price.

Q3. What are the P/E and P/B ratios of Skybiotech Healthcar?
Ans: The PE ratio of Skybiotech Healthcar is -175.08557683412 and the P/B ratio of Skybiotech Healthcar is 3.08384975255874, showing how the stock is valued against its earnings and book value.

Q4. What is the 52-week high and low of Skybiotech Healthcar share?
Ans: The 52-week high share price of Skybiotech Healthcar is Rs 350.8, and the 52-week low share price of Skybiotech Healthcar is Rs 127.45.

Q5. Does Skybiotech Healthcar pay dividends?
Ans: Currently, Skybiotech Healthcar does not pay dividends. Dividend yield of Skybiotech Healthcar is around 0%.

Q6. What are the face value and book value of Skybiotech Healthcar shares?
Ans: The face value of Skybiotech Healthcar shares is Rs 10, while the book value per share of Skybiotech Healthcar is around Rs 61.3681. Face value is the nominal value set by the company, whereas book value reflects its accounting worth.

Q7. What is the debt of Skybiotech Healthcar?
Ans: Skybiotech Healthcar has a total debt of Rs 0 Cr., which affects investor sentiment and financial stability. 

Q8. What are the ROE and ROCE of Skybiotech Healthcar?
Ans: The ROE of Skybiotech Healthcar is 0.528% and ROCE of Skybiotech Healthcar is 0.6731%. ROE shows how efficiently the company is generating profit from shareholders’ equity, while the ROCE is reflects how efficiently the company uses its capital to generate returns.

Q9. Is Skybiotech Healthcar a good buy for the long term?
Ans: The Skybiotech Healthcar long-term outlook depends on debt levels, earnings growth, and sector trends. If it sustains profits and manages debt well, it may be considered for long-term investment.

Q10. Is Skybiotech Healthcar undervalued or overvalued?
Ans: Based on valuation ratios like P/E, P/B, and EV/EBITDA, one can analyse whether the Skybiotech Healthcar appears undervalued or overvalued at current levels. You can check detailed valuation metrics and peer comparisons on Finology Ticker.

Q11. How to check Skybiotech Healthcar’s financials?
Ans: You can review Skybiotech Healthcar’s financial statements - including balance sheet, income statement, and quarterly results - on Finology Ticker.